Stay updated on Tucatinib Plus Trastuzumab in HER2+ Colorectal Cancer Clinical Trial

Sign up to get notified when there's something new on the Tucatinib Plus Trastuzumab in HER2+ Colorectal Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Tucatinib Plus Trastuzumab in HER2+ Colorectal Cancer Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The record history now reflects a newer revision tag, updating from v3.5.2 to v3.5.3. This indicates an updated version of the study record history on the page.
    Difference
    0.0%
    Check dated 2026-04-30T17:42:01.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    Added Revision: v3.5.2 and removed Revision: v3.5.0 in the record history.
    Difference
    0.0%
    Check dated 2026-04-16T11:00:10.000Z thumbnail image
  4. Check
    27 days ago
    No Change Detected
  5. Check
    48 days ago
    Change Detected
    Summary
    Added revision v3.5.0 to the record history and removed revision v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-18T17:44:12.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    Added Revision: v3.4.3 and removed Revision: v3.4.2 on the Record History page.
    Difference
    0.0%
    Check dated 2026-03-11T15:28:59.000Z thumbnail image
  7. Check
    83 days ago
    Change Detected
    Summary
    A new revision entry v3.4.2 was added to the history. The funding notice and the previous revision v3.4.1 were removed from the history.
    Difference
    0.4%
    Check dated 2026-02-11T09:19:04.000Z thumbnail image
  8. Check
    91 days ago
    Change Detected
    Summary
    Added a site-wide notice about government funding and operations. Updated the page revision to v3.4.1 (replacing v3.4.0).
    Difference
    0.4%
    Check dated 2026-02-04T05:30:26.000Z thumbnail image

Stay in the know with updates to Tucatinib Plus Trastuzumab in HER2+ Colorectal Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Tucatinib Plus Trastuzumab in HER2+ Colorectal Cancer Clinical Trial page.